Expert Opinion on Therapeutic Targets
Taylor and Francis Ltd. · England
Metrics
- Impact factor
- 5.1+0.7 Clarivate JCR
- WoS quartile
- Q1 Clarivate JCR, best category
- SJR
- 1.383Q1 SCImago
- h-index
- 78
- CAS tier
- Tier 2 Chinese Academy of Sciences
- Citations per paper
- 4.52 last 2 years
- Articles per year
- 70
- Self-citation
- 2.2%
- Fee (APC), est.
- $3,550 estimated, check the journal
About this journal
- ISSN
- 1472-8222 (print) · 1744-7631 (online)
- Publisher
- Taylor and Francis Ltd. · Taylor & Francis
- Country
- England · Western Europe
- Indexed in
- SCIE
- Access
- Hybrid · 11.5% gold OA
- Founded
- 2001
- Frequency
- Monthly
- Original research
- 14.5%
- Subject areas
- Biochemistry, Genetics and Molecular Biology, Pharmacology, Toxicology and Pharmaceutics
- Categories
- Medicine, Pharmacy
- Common topics
- Medicine, Biology, Internal medicine, Genetics, Chemistry
Similar journals
- Q1WoS
Cell
Impact factor 45.1h-index 705SJR 24.59 - Q1WoS
Journal of the American Chemical Society
Impact factor 16.6h-index 542SJR 5.49 - Q1WoS
Nature Genetics
Impact factor 25.5h-index 527SJR 15.38 - Q1WoS
Nature Medicine
Impact factor 52.5h-index 497SJR 17.50 - Q1WoS
Journal of Clinical Oncology
Impact factor 44.7h-index 494SJR 4.65 - Q1WoS
Nucleic Acids Research
Impact factor 15h-index 452SJR 8.11
Figures as of the last import; ranks are a guide, not a verdict. Back to all journals